DK2379557T3 - Aminopyrazol-forbindelse - Google Patents

Aminopyrazol-forbindelse

Info

Publication number
DK2379557T3
DK2379557T3 DK09795842.5T DK09795842T DK2379557T3 DK 2379557 T3 DK2379557 T3 DK 2379557T3 DK 09795842 T DK09795842 T DK 09795842T DK 2379557 T3 DK2379557 T3 DK 2379557T3
Authority
DK
Denmark
Prior art keywords
aminopyrazole
Prior art date
Application number
DK09795842.5T
Other languages
English (en)
Inventor
Timothy Paul Burkholder
Joshua Ryan Clayton
Liandong Ma
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=41630090&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK2379557(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Application granted granted Critical
Publication of DK2379557T3 publication Critical patent/DK2379557T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/50—Pyridazines; Hydrogenated pyridazines
    • A61K31/5025—Pyridazines; Hydrogenated pyridazines ortho- or peri-condensed with heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
DK09795842.5T 2008-12-16 2009-12-08 Aminopyrazol-forbindelse DK2379557T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US12285408P 2008-12-16 2008-12-16
PCT/US2009/067056 WO2010074947A1 (en) 2008-12-16 2009-12-08 Amino pyrazole compound

Publications (1)

Publication Number Publication Date
DK2379557T3 true DK2379557T3 (da) 2012-12-17

Family

ID=41630090

Family Applications (1)

Application Number Title Priority Date Filing Date
DK09795842.5T DK2379557T3 (da) 2008-12-16 2009-12-08 Aminopyrazol-forbindelse

Country Status (39)

Country Link
US (2) US7897600B2 (da)
EP (1) EP2379557B1 (da)
JP (1) JP5509217B2 (da)
KR (1) KR101300458B1 (da)
CN (1) CN102232075B (da)
AR (1) AR074240A1 (da)
AU (1) AU2009330503B2 (da)
BR (1) BRPI0923048A2 (da)
CA (1) CA2744714C (da)
CL (1) CL2011001445A1 (da)
CO (1) CO6331442A2 (da)
CR (1) CR20110341A (da)
CY (1) CY1113637T1 (da)
DK (1) DK2379557T3 (da)
DO (1) DOP2011000190A (da)
EA (1) EA019554B1 (da)
EC (1) ECSP11011132A (da)
ES (1) ES2396617T3 (da)
HK (1) HK1160109A1 (da)
HN (1) HN2011001697A (da)
HR (1) HRP20120918T1 (da)
IL (1) IL213065A0 (da)
JO (1) JO2833B1 (da)
MA (1) MA32900B1 (da)
MX (1) MX2011006441A (da)
MY (1) MY158691A (da)
NZ (1) NZ592641A (da)
PA (1) PA8851101A1 (da)
PE (1) PE20110549A1 (da)
PL (1) PL2379557T3 (da)
PT (1) PT2379557E (da)
SG (1) SG172202A1 (da)
SI (1) SI2379557T1 (da)
SV (1) SV2011003949A (da)
TN (1) TN2011000292A1 (da)
TW (1) TWI440640B (da)
UA (1) UA104743C2 (da)
WO (1) WO2010074947A1 (da)
ZA (1) ZA201103942B (da)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2435646A (en) * 2006-03-01 2007-09-05 Spin Tec Engineering Gmbh Apparatus and method of extraction of an arthropod gland
US8105633B2 (en) * 2006-03-01 2012-01-31 Spintec Engineering Gmbh Method and apparatus for extraction of arthropod gland
US20110121485A1 (en) * 2006-10-30 2011-05-26 Spintec Engineering Gmbh Method and apparatus for the manufacture of a fiber
CN103458970A (zh) * 2011-03-07 2013-12-18 泰莱托恩基金会 Tfeb磷酸化抑制剂及其应用
JP6228113B2 (ja) * 2011-06-15 2017-11-08 ライフ・アンド・ブレイン・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツングＬＩＦＥ ＡＮＤ ＢＲＡＩＮ ＧｍｂＨ グリア芽腫阻害化合物およびその使用
AU2013280644B2 (en) 2012-06-26 2018-08-02 Jeffrey A. BACHA Methods for treating tyrosine-kinase-inhibitor-resistant malignancies in patients with genetic polymorphisms or AHI1 dysregulations or mutations employing dianhydrogalactitol, diacetyldianhydrogalactitol, dibromodulcitol, or analogs or derivatives thereof
PL400213A1 (pl) 2012-08-01 2014-02-03 Celon Pharma Spólka Z Ograniczona Odpowiedzialnoscia Pochodne imidazo[1,2-b]pirydazyno-6-aminy jako inhibitory kinazy JAK-2
WO2016024232A1 (en) 2014-08-11 2016-02-18 Acerta Pharma B.V. Therapeutic combinations of a btk inhibitor, a pi3k inhibitor, a jak-2 inhibitor and/or a cdk 4/6 inhibitor
PL3179991T3 (pl) 2014-08-11 2022-02-14 Acerta Pharma B.V. Kombinacje terapeutyczne inhibitora btk i inhibitora bcl-2
WO2016024231A1 (en) 2014-08-11 2016-02-18 Acerta Pharma B.V. Therapeutic combinations of a btk inhibitor, a pi3k inhibitor, a jak-2 inhibitor, a pd-1 inhibitor and/or a pd-l1 inhibitor
CN110191887B (zh) * 2016-11-17 2022-02-18 百时美施贵宝公司 IL-12、IL-23和/或IFN-α的咪唑并哒嗪调节剂
WO2018167283A1 (en) 2017-03-17 2018-09-20 INSERM (Institut National de la Santé et de la Recherche Médicale) Methods for the diagnosis and treatment of pancreatic ductal adenocarcinoma associated neural remodeling
WO2018189335A1 (en) 2017-04-13 2018-10-18 INSERM (Institut National de la Santé et de la Recherche Médicale) Methods for the diagnosis and treatment of pancreatic ductal adenocarcinoma
WO2020092015A1 (en) 2018-11-02 2020-05-07 University Of Rochester Therapeutic mitigation of epithelial infection
CN110305140B (zh) 2019-07-30 2020-08-04 上海勋和医药科技有限公司 二氢吡咯并嘧啶类选择性jak2抑制剂

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030105090A1 (en) 2000-12-21 2003-06-05 David Bebbington Pyrazole compounds useful as protein kinase inhibitors
JP2003137785A (ja) * 2001-08-23 2003-05-14 Takeda Chem Ind Ltd Ｊｎｋ活性化阻害剤
JP4556020B2 (ja) 2001-12-21 2010-10-06 ジェンザイム・コーポレーション 高い有効性を有するケモカインレセプタ結合複素環式化合物
KR101362621B1 (ko) 2005-02-16 2014-02-13 아스트라제네카 아베 화합물
AU2006215394B2 (en) 2005-02-16 2009-10-08 Astrazeneca Ab Chemical compounds
RU2386630C2 (ru) * 2005-07-01 2010-04-20 Айрм Ллк Соединения и композиции в качестве ингибиторов протеинтирозинкиназы
GB0515026D0 (en) * 2005-07-21 2005-08-31 Novartis Ag Organic compounds
AR055206A1 (es) * 2005-10-06 2007-08-08 Schering Corp Pirazolo[1, 5 - a]pirimidinas como inhibidoras de proteina quinasa, composiciones farmaceuticas y combinaciones con agentes citostaticos que las comprenden y su uso en la fabricacion de un medicamento para el tratamiento del cancer.
EP1931676B1 (en) * 2005-10-06 2011-11-16 Schering Corporation Pyrazolopyrimidines as protein kinase inhibitors
CA2630884A1 (en) 2005-11-30 2007-06-07 Vertex Pharmaceuticals Incorporated Inhibitors of c-met and uses thereof
US7989459B2 (en) 2006-02-17 2011-08-02 Pharmacopeia, Llc Purinones and 1H-imidazopyridinones as PKC-theta inhibitors
US20110021513A1 (en) 2006-09-07 2011-01-27 Biogen Idec Ma Inc. Modulators of interleukin-1 receptor-associated kinase
CN101522682A (zh) * 2006-10-30 2009-09-02 诺瓦提斯公司 作为抗炎剂的杂环化合物
EP2155742A1 (en) * 2007-04-18 2010-02-24 AstraZeneca AB 5-aminopyrazol-3-yl-3h-imidazo [4,5-b]pyridine derivatives and their use for the treatment of cancer
CA2686485A1 (en) 2007-05-23 2008-11-27 Pharmacopeia, Llc Purinones and 1h-imidazopyridinones as pkc-theta inhibitors
WO2009062059A2 (en) 2007-11-08 2009-05-14 Pharmacopeia, Inc. Isomeric purinones and 1h-imidazopyridinones as pkc-theta inhibitors

Also Published As

Publication number Publication date
IL213065A0 (en) 2011-07-31
CN102232075A (zh) 2011-11-02
AR074240A1 (es) 2011-01-05
HN2011001697A (es) 2013-11-26
AU2009330503B2 (en) 2012-06-07
SI2379557T1 (sl) 2013-02-28
SG172202A1 (en) 2011-07-28
EP2379557B1 (en) 2012-10-31
HK1160109A1 (en) 2012-08-10
JP2012512158A (ja) 2012-05-31
JP5509217B2 (ja) 2014-06-04
CY1113637T1 (el) 2016-06-22
MY158691A (en) 2016-10-31
US20100152181A1 (en) 2010-06-17
EP2379557A1 (en) 2011-10-26
TW201024301A (en) 2010-07-01
CL2011001445A1 (es) 2011-11-11
US7897600B2 (en) 2011-03-01
PE20110549A1 (es) 2011-08-04
TWI440640B (zh) 2014-06-11
HRP20120918T1 (hr) 2012-12-31
KR101300458B1 (ko) 2013-08-30
CO6331442A2 (es) 2011-10-20
CA2744714A1 (en) 2010-07-01
ECSP11011132A (es) 2011-07-29
MA32900B1 (fr) 2011-12-01
SV2011003949A (es) 2011-07-21
EA201170831A1 (ru) 2011-12-30
CA2744714C (en) 2013-06-25
WO2010074947A1 (en) 2010-07-01
AU2009330503A1 (en) 2010-07-01
ZA201103942B (en) 2012-08-29
BRPI0923048A2 (pt) 2018-09-25
PA8851101A1 (es) 2010-07-27
JO2833B1 (en) 2014-09-15
PL2379557T3 (pl) 2013-03-29
CN102232075B (zh) 2013-12-11
MX2011006441A (es) 2011-07-19
PT2379557E (pt) 2013-01-14
CR20110341A (es) 2011-07-13
ES2396617T3 (es) 2013-02-22
US20100286139A1 (en) 2010-11-11
NZ592641A (en) 2013-01-25
UA104743C2 (ru) 2014-03-11
KR20110084993A (ko) 2011-07-26
DOP2011000190A (es) 2011-07-31
TN2011000292A1 (en) 2012-12-17
EA019554B1 (ru) 2014-04-30

Similar Documents

Publication Publication Date Title
DK2370462T3 (da) Glucagon-analoger
BRPI0907376A2 (pt) Fotobiorretador
DK2342317T3 (da) Hængende-dråbe-plade
DE602009000234D1 (de) msignals
DK3444343T3 (da) Polypeptider
BRPI0914649A2 (pt) Piprazolo-quinazolinas
DE602008003972D1 (de) Sitzrücklehnungsmechanismus
DE602008003521D1 (de) Sitzrücklehnungsmechanismus
DK2336132T3 (da) Morpholinpurinderivat
DK2335031T3 (da) In-line-måler
DK2342454T3 (da) Vindkraftanlæg
DK2379557T3 (da) Aminopyrazol-forbindelse
DE602008003970D1 (de) Strahlstromkalibriersystem
DK2271613T3 (da) Hydroxymethylcyklohexylaminer
BRPI0907522A2 (pt) biarlamidas
DE112009001946A5 (de) Mobelauszugsführung
BRPI0907863A2 (pt) pirrolopirimidinacarboxamidas
BRPI0909634A2 (pt) 2-aminoquinolinas
DE112009000183A5 (de) Sicherheitsvorreiber
BRPI0909637A2 (pt) 2-aminoquinolinas
DE602009000862D1 (de) Gehwagenbremse
AT507449A3 (de) Dämmstoffbefestiger
DK2344933T3 (da) Uretui
DE602009001190D1 (de) Gleichstromumrichtervorrichtung
ES1067763Y (es) Dendrometro